Synonyms:gliclazide, 21187-98-4, Glimicron, 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea, 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea, CHEBI:31654, 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea, Gliclazidum [INN-Latin], Gliclazida [INN-Spanish], Gliclazida, N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide, DTXSID9023095, 1-[(4-methylbenzene)sulfonyl]-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea, NSC-758673, SE-1702, S1702;SE1702, DTXCID003095, S-852, S-1702, N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea, 1-(4-methylbenzenesulfonyl)-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea, N-((hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide, Glimicron (TN), SMR000542971, SR-01000816184, 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-p-tolylsulphonylurea, MFCD00409893, J3.151H, Gliclazide,(S), Benzenesulfonamide, N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-, NCGC00016751-01, Prestwick_869, CAS-21187-98-4, Gliclazide (Diamicron), Spectrum_001478, SpecPlus_000870, Prestwick0_000558, Prestwick1_000558, Prestwick2_000558, Prestwick3_000558, Spectrum3_001862, Spectrum4_000598, Spectrum5_000753, Gliclazide (JP17/INN), SCHEMBL16387, BSPBio_000635, BSPBio_003304, KBioGR_001096, KBioSS_001958, MLS001215197, MLS001304077, MLS001304118, DivK1c_006966, Gliclazide, powder, >=98%, SPECTRUM1504145, SPECTRUM1505013, SPBio_002556, BPBio1_000699, CHEMBL427216, Urea, 1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-, KBio1_001910, KBio2_001958, KBio2_004526, KBio2_007094, KBio3_002806, 1-[3-Azabicyclo[3.3.0]oct-3-yl]-3-p-toluenesulfonylurea, HMS1569P17, HMS1922D15, HMS2090K16, HMS2096P17, HMS2855P09, HMS3656C22, HMS3713P17, HMS3744O13, Pharmakon1600-01504145, BCP21240, HY-B0753, Tox21_110590, BBL012275, BDBM50103512, NSC758673, NSC813216, s2601, SE1702, STK803142, AKOS003237903, AKOS016340698, Tox21_110590_1, AB05958, CCG-213918, DB01120, KS-1067, NSC-813216, N-[(hexahydrocyclopenta[c]pyrrol-2(1H)-ylamino)carbonyl]-4-methylbenzenesulfonamide, NCGC00095107-01, NCGC00095107-02, NCGC00095107-03, NCGC00095107-04, NCGC00095107-05, NCGC00095107-06, NCGC00095107-09, NCGC00095107-10, AC-12045, SBI-0052662.P002, AB00053165, FT-0626712, G0381, SW196994-3, D01599, D83168, AB00053165-09, AB00053165_10, AB00053165_11, EN300-7359575, A815188, Q290001, J-013905, J-522753, SR-01000816184-2, SR-01000816184-3, SR-01000816184-4, BRD-A61154809-001-04-3, Gliclazide, British Pharmacopoeia (BP) Reference Standard, Gliclazide, European Pharmacopoeia (EP) Reference Standard, 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonyl-urea, 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(4-methylphenyl)sulfonyl]urea, Benzenesulfonamide,N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-, BENZENESULFONAMIDE, N-[[(HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)-YL)AMINO]CARBONYL]-4-METHYL
Pubchem:PUBCHEM:3475
Id:711f63be-d671-5c1f-b4e7-8b641f14a081
Description:nan
